U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354789) titled 'The Feasibility, Safety, and Efficacy of EUS-Guided PSE: A Cohort Study' on Dec. 01, 2025.
Brief Summary: Bleeding from esophagogastric varices in patients with liver cirrhosis is often life-threatening. Thrombocytopenia caused by hypersplenism secondary to portal hypertension is an independent risk factor for such gastrointestinal bleeding. Studies have confirmed that partial splenic embolization (PSE) can effectively reduce portal pressure and decrease the risk of rebleeding.
Traditional treatments mainly include total splenectomy and X-ray-guided transarterial partial splenic embolization (X-PSE). Although total splenectomy can ...